DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS

Objective — to evaluate the relationship between antibody titers against modified citrullinated vimentin (AMCV), IgM rheumatoid factor (RF), interleukin (IL) 4, IL6 and IL8, and their correlation with rheumatoid arthritis (RA) activity indicators, systemic manifestations, evolution of disease activi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Sergeevna Voronina, A A Vinogradov, N P Shilkina
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2012-10-01
Series:	Научно-практическая ревматология
Subjects:	antibodies against modified citrullinated vimentin interleukin 6 rheumatoid arthritis methotrexate
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1091
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01)

Antibodies against post-translationally modified vimentin peptides in patients with rheumatoid arthritis
by: P. A. Kuznetsova, et al.
Published: (2017-09-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

Role of ultrasonic examination in assessment of the knee-joint state in patients with juvenile idiopathic arthritis
by: V. O. Roschina, et al.
Published: (2012-10-01)

Cytokines, chemokines and antibodies against histone-3/4 citrullinated peptides in rheumatoid arthritis patients with pulmonary fibrosis
by: Linda Johansson, et al.
Published: (2025-07-01)

Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry
by: Andreina Manfredi, et al.
Published: (2019-01-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
by: E. L. Nasonov
Published: (2017-04-01)

CHARACTERISTICS OF AUTOIMMUNE INFLAMMATION IN THE PATIENTS WITH LUNG TUBERCULOSIS
by: A. A. Starshinova, et al.
Published: (2019-12-01)

Seropositive juvenile rheumatoid arthritis: analysis of the spectrum of clinical manifestations and therapy according to a retrospective study
by: М. I. Kaleda, et al.
Published: (2021-02-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

ACCP-negative rheumatoid arthritis – clinical and immunological features
by: D. A. Dibrov
Published: (2022-07-01)

Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides
by: Isabel Haro, et al.
Published: (2024-11-01)

Evaluation of Serum IL-41 as a Potential Biomarker in a Group of Iraqi Patients with Rheumatoid Arthritis
by: Ayat F. Tawfeeq, et al.
Published: (2025-04-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
by: E. L. Nasonov, et al.
Published: (2023-06-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

Relation of cytokine profile and antibody values to post-translational protein modifications in patients with rheumatoid arthritis (preliminary data)
by: D. А. Dibrov, et al.
Published: (2024-04-01)

Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2023-04-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Autoantibodies as prognostic markers in rheumatoid arthritis
by: Carl Turesson, et al.
Published: (2025-06-01)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
by: I. B. Belyaeva, et al.
Published: (2014-07-01)

Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies – comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis
by: Tineke J. van Wesemael, et al.
Published: (2025-05-01)

PENTOXIFILLIN INTHETREATMENTOF RHEUMATOID ARTHRITIS
by: I R Kolosova, et al.
Published: (2001-10-01)

Combined disease modifying treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine
by: N A Sergiets, et al.
Published: (2009-02-01)

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E E Gubar', et al.
Published: (2011-04-01)

Efficacy and safety of rapid dose escalation of methotrexate in rheumatoid arthritis. Results of the multicenter “METEOR” study
by: V. N. Amirjanova, et al.
Published: (2025-03-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

Triple positivity for autoantibodies in patients with rheumatoid arthritis is associated with a severe course of the disease but not with bone turnover markers
by: Tomasz Budlewski, et al.
Published: (2025-04-01)

DIAGNOSTIC VALUE OF SEROLOGICAL MARKERS OF RHEUMATOID ARTHRITIS
by: Aleksei Leonidovich Maslaynski, et al.
Published: (2012-10-01)

Early rheumatoid arthritis therapy: comparative characteristic of delagil, sulphasalazine and methotrexate
by: T S Salnikova, et al.
Published: (2003-08-01)

Rheumatoid arthritis: problems of treatment at the present stage
by: N. V. Chichasova
Published: (2018-12-01)

Current state and future directions of basic research in rheumatoid arthritis
by: Byeongzu Ghang, et al.
Published: (2025-07-01)

Predictor Response of Monotherapy with Methotrexate with Triple DMARDS Therapy in Patients of Rheumatoid Arthritis
by: Babar Ejaz, et al.
Published: (2025-01-01)

POSSIBILITY OF ANTIDESTRUCTIVE EFFECT OF LOW DOSES OF CORTICOSTEROIDS IN RHEUMATOID ARTHRITIS: PRELIMINARY INFORMATION
by: N A Grunina, et al.
Published: (2000-02-01)

SYNOVIAL MEMBRANE CHANGES IN PATIENTS WITH RHEUMATOID ARTHRITIS REVEALED DURING ARTHROSCOPY
by: E. B. Komarova
Published: (2017-07-01)

Adherence to Parenteral Methotrexate Compared to Oral Route in Patients with Rheumatoid Arthritis
by: Mariwan Ismail Othman, et al.
Published: (2025-03-01)

Relationship of immunogenetic and immunologic markers and their influence on disease activity and radiological progression in patients with early rheumatoid arthritis
by: N V Demidova
Published: (2009-06-01)